YA II PN, Ltd. 13D and 13G filings for Q BioMed Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-04 6:00 pm Sale |
2024-09-30 | 13G | Q BioMed Inc. QBIO |
YA II PN, Ltd. | 0 0.000% |
-10,207,532 (Position Closed) |
Filing |
| 2023-01-03 3:45 pm Purchase |
2022-12-31 | 13G | Q BioMed Inc. QBIO |
YA II PN, Ltd. | 10,207,532 9.990% |
7,522,581 (+280.18%) |
Filing |
| 2023-01-03 3:28 pm Purchase |
2022-12-31 | 13G | Q BioMed Inc. QBIO |
YA II PN, Ltd. | 425,502 9.990% |
213,943 (+101.13%) |
Filing |
| 2022-01-11 5:12 pm Purchase |
2021-12-31 | 13G | Q BioMed Inc. QBIO |
YA II PN, Ltd. | 211,559 9.990% |
211,559 (New Position) |
Filing |
| 2021-02-04 7:43 pm Purchase |
2020-12-31 | 13G | Q BioMed Inc. QBIO |
YA II PN, Ltd. | 2,684,951 9.990% |
313,357 (+13.21%) |
Filing |